Cas 1004979-34-3,((7-((acetylamino)(3,4-dimethoxyphenyl)methyl)-5-chloroquinolin-8-yl)oxy)methyl dihydrogen phosphate

1004979-34-3

Post Buying Request

Basic information

Product Name: ((7-((acetylamino)(3,4-dimethoxyphenyl)methyl)-5-chloroquinolin-8-yl)oxy)methyl dihydrogen phosphate
Synonyms: ((7-((acetylamino)(3,4-dimethoxyphenyl)methyl)-5-chloroquinolin-8-yl)oxy)methyl dihydrogen phosphate
CAS NO:1004979-34-3
Molecular Formula:
Molecular Weight: 496.841
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: ((7-((acetylamino)(3,4-dimethoxyphenyl)methyl)-5-chloroquinolin-8-yl)oxy)methyl dihydrogen phosphate(CAS DataBase Reference)
NIST Chemistry Reference: ((7-((acetylamino)(3,4-dimethoxyphenyl)methyl)-5-chloroquinolin-8-yl)oxy)methyl dihydrogen phosphate(1004979-34-3)
EPA Substance Registry System: ((7-((acetylamino)(3,4-dimethoxyphenyl)methyl)-5-chloroquinolin-8-yl)oxy)methyl dihydrogen phosphate(1004979-34-3)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1004979-34-3(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1004979-34-3 Suppliers

Recommended suppliers

1004979-34-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1004979-34-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,4,9,7 and 9 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1004979-34:
(9*1)+(8*0)+(7*0)+(6*4)+(5*9)+(4*7)+(3*9)+(2*3)+(1*4)=143
143 % 10 = 3
So 1004979-34-3 is a valid CAS Registry Number.

1004979-34-3Upstream product

1004980-19-1 C₃₅H₃₄ClN₂O₈P

1004979-34-3Downstream Products

1004979-34-3Relevant academic research and scientific papers

QUINOLINE DERIVATIVES

-

Page/Page column 57; 59, (2008/06/13)

The invention relates to new quinoline derivatives which are active CLK-1 inhibitors. More specifically, the CLK-1 inhibitors of the invention are compounds of formula (A). The invention also relates to pharmaceutical compositions comprising such compounds and to methods for the prophylaxis and/or treatment of disorders or their associated symptoms for which the inhibition of CLK-1 is beneficial.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1004979-34-3